The SEM study of PNH erythrocytes which survived incubations with decreasing dilutions (from 1:640 to 1:20) of fresh compatible serum in isotonic sucrose has indirectly evidenced that spherocytes and spherostomatocytes are the most sensitive population to the complement lytic action; swelling is an osmotic consequence of their membrane hypersusceptibility. In such functional abnormality the swollen red cells are closely followed by the cribrous and pitted erythrocytes. A relationship has been found between percentage of the swollen cells and frequency of PNH haemolytic bouts: these are most likely to occur when spherocytes and spherostomatocytes are above 40% of cells. On the contrary, SEM evaluation of swollen erythrocytes does not allow to express any long-term prognosis about the severity and the course of PNH, owing to the constantly variable marrow production of abnormal erythrocytes.

Keywords:
Paroxysmal nocturnal haemoglobinuria, Scanning electron microscopy, Complement-sensitive erythrocytes
This content is only available via PDF.
© 1978 S. Karger AG, Basel
1978
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.